Kang, Liu <br/><br/>
Dexmedetomidine attenuates P2X4 and NLRP3 expression in the spine of rats with diabetic neuropathic pain.  [electronic resource] 

 -  Acta cirurgica brasileira  2019 
 - e201901105 p.  digital 
<br/><br/> Publication Type: Evaluation Study; Journal Article 
<br/><br/><label>ISSN: </label>1678-2674 
<br/><br/><label>Standard No.: </label>10.1590/s0102-865020190110000005  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adrenergic alpha-2 Receptor Agonists--pharmacology<br/>Animals<br/>Blotting, Western<br/>Dexmedetomidine--pharmacology<br/>Diabetes Mellitus, Experimental--drug therapy<br/>Diabetic Neuropathies--drug therapy<br/>Disease Models, Animal<br/>Interleukin-1beta--analysis<br/>Male<br/>Microscopy, Electron, Transmission<br/>NLR Family, Pyrin Domain-Containing 3 Protein--analysis<br/>Neural Conduction--drug effects<br/>Pain Threshold<br/>Random Allocation<br/>Rats, Sprague-Dawley<br/>Receptors, Purinergic P2X4--analysis<br/>Reproducibility of Results<br/>Signal Transduction--drug effects<br/>Spine--drug effects<br/>Streptozocin<br/>Sural Nerve--drug effects<br/>Time Factors